Abivax completes induction treatment of last patient in ABX464 phase 2b clinical study in ulcerative colitis

Written by Petra Hegmann on 14th April 2021. Posted in Client News.

[image_slider_no_space on_click=”prettyphoto” height=”600″ navigation_style=”light” images=”940,950,954,952,953,951″]